amifostine anhydrous has been researched along with cyclic gmp in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catravas, GN; Trocha, PJ | 1 |
| Carrithers, SL; Lefer, AM; Nuss, C; Owen, CS; Parkinson, SJ; Pooler, PM; Ryan, SV; Skurk, C; Waldman, SA | 1 |
| Anfossi, G; Massucco, P; Mattiello, L; Russo, I; Trovati, M | 1 |
| Anfossi, G; Barale, C; Cavalot, F; Doronzo, G; Mattiello, L; Pagliarino, A; Russo, I; Trovati, M; Viretto, M | 1 |
4 other study(ies) available for amifostine anhydrous and cyclic gmp
| Article | Year |
|---|---|
Effect of radioprotectant WR 2721 on cyclic nucleotides, prostaglandins, and lysosomes.
Topics: Amifostine; Animals; Cyclic AMP; Cyclic GMP; Glucuronidase; Intracellular Membranes; Liver; Lysosomes; Male; Nucleotides, Cyclic; Organothiophosphorus Compounds; Prostaglandins; Rats; Rats, Inbred Strains; Spleen; Time Factors; Whole-Body Irradiation | 1983 |
Hypotensive mechanisms of amifostine.
Topics: Adrenergic Agents; Amifostine; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Calcium; Cyclic AMP; Cyclic GMP; Ephedrine; Hypotension; In Vitro Techniques; Ligands; Male; Mercaptoethylamines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Radiation-Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha | 1996 |
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects.
Topics: Acetylcysteine; Adenosine Diphosphate; Adult; Amifostine; Antioxidants; Collagen; Cyclic GMP; Drug Resistance; Female; Free Radical Scavengers; Humans; Insulin Resistance; Male; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Obesity; Platelet Aggregation; Platelet Aggregation Inhibitors; Superoxide Dismutase | 2003 |
High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets.
Topics: Adult; Amifostine; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cell Adhesion Molecules; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Drug Resistance; Female; Humans; Hyperglycemia; Lysine; Male; Microfilament Proteins; Nitric Oxide; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Protein Processing, Post-Translational; Second Messenger Systems; Thromboxanes; Vasodilator Agents; Young Adult | 2012 |